Skip to main content
Study

Risk factors for adverse events in patients with breast, colorectal, and lung cancer.

Weingart SN, Atoria CL, Pfister D, et al. Risk Factors for Adverse Events in Patients With Breast, Colorectal, and Lung Cancer. J Patient Saf. 2021;17(8):e701-e707. doi:10.1097/pts.0000000000000474.

Save
Print
May 23, 2018
Weingart SN, Atoria CL, Pfister D, et al. J Patient Saf. 2021;17(8):e701-e707.

This retrospective cohort study identified frequent treatment-related adverse events for patients with breast, colorectal, or lung cancer, with 34% of patients experiencing an adverse event during their treatment course. Advanced disease and chemotherapy conferred higher risk for adverse events, as did non-White race and Hispanic ethnicity. The authors suggest that such factors could be used for prospective identification of patients at highest risk for adverse events.

Save
Print
Cite
Citation

Weingart SN, Atoria CL, Pfister D, et al. Risk Factors for Adverse Events in Patients With Breast, Colorectal, and Lung Cancer. J Patient Saf. 2021;17(8):e701-e707. doi:10.1097/pts.0000000000000474.